Pharmacokinetics of [14C]genistein in the rat: Gender-related differences, potential mechanisms of biological action, and implications for human health

Toxicology and Applied Pharmacology

Volumn 164, Issue 2, 2000, Pages 206-215

  Coldham, Nick G ^a   Sauer, Maurice J ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

ADME; Genistein; Mechanisms of action; Rat

Indexed keywords

CARBON 14; GENISTEIN; ISOFLAVONOID; PHYTOESTROGEN; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; DRUG METABOLISM; DRUG PROTEIN BINDING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MALE; MASS SPECTROMETRY; NONHUMAN; RAT; SEX DIFFERENCE; TISSUE DISTRIBUTION; ANIMAL; AREA UNDER THE CURVE; BLOOD; INTESTINE ABSORPTION; METABOLISM; ORAL DRUG ADMINISTRATION; WISTAR RAT;

ANIMALIA;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; AREA UNDER CURVE; BIOTRANSFORMATION; FEMALE; GENISTEIN; INTESTINAL ABSORPTION; MALE; RATS; RATS, WISTAR; SEX FACTORS; TISSUE DISTRIBUTION;

EID: 0034654655     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.2000.8902     Document Type: Article

References (40)

1. Adlercreutz H., Fotsis T., Heikkinen R., Dwyer J. T., Woods M., Goldin B. R., Gorbach S. L. Excretion of the lignans enterolactone and enterodiol and of equol in omnivorous and vegetarian women and in women with breast cancer. Lancet. 2:1982;1295-1299.
2. Akiyama T. J., Ishida S., Nakagawa H., Ogawara S., Watanabe N. M., Itoh M., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
3. Baird D. D., Umbach D. M., Lansdell L., Hughes C. L., Setchell K. D. R., Weinberg C. R., Haney A. F., Wilcox A. J., McLachlan J. A. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J. Clin. Endocrinol. Metab. 80:1995;1685-1690.
4. Barnes S., Coward L., Kirk M., Sfakianos J. HPLC-mass spectrometry analysis of isoflavones. Proc. Soc. Exp. Biol. Med. 217:1998;254-262.
5. Barnes S., Sfakianos J., Coward L., Kirk M. Soy isoflavonoids and cancer prevention. Adv. Exp. Med. Biol. 401:1996;87-100.
6. Barnes S., Grubbs C., Setchell K. D. R., Carlson J. Soybeans inhibit mammary tumours in models of breast cancer. Prog. Clin. Biol. Res. 347:1990;239-253.
7. Blair H., Jordan S. E., Peterson T. G., Barnes S. Various effects of tyrosine kinase inhibitors on avain osteoclastic activity and reduction of bone loss in ovariectomised rats. J. Cell Biochem. 61:1996;629-637.
8. Brandenberger A. W., Tee M. K., Lee J. Y., Chao V., Jaffe R. B. Tissue distribution of estrogen receptors alpha (ER-α) and beta (ER-β) mRNA in the midgestational human fetus. J. Clin. Endocrinol. Metab. 82:1997;3509-3512.
9. Burne J. Battle of Hearts and Hormones: The Financial Times 2. 1999;Financial Times, Ltd. London. p. 2.
10. Cassidy A., Bingham S., Setchell K. D. R. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am. J. Clin. Nutr. 60:1994;333-340.
11. Cimino C. O., Shelnutt S. R., Ronis M. J., Badger T. M. An LC-MS method to determine concentrations of isoflavones and their sulphate and glucuronide conjugates in urine. Clin. Chim. Acta. 287:1999;69-82.
12. Coldham N. G., Howells L. C., Santi A., Montesissa C., Langlais C., King L. C., Macpherson D. D., Sauer M. J. Biotransformation of genistein in the rat: Elucidation of metabolite structure by product ion mass fragmentology. J. Steroid Biochem. Mol. Biol. 70:1999;169-184.
13. Couse J. F., Lindzey J., Grandien K., Gustafsson J., Korach K. S. Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology. 138:1997;4613-4621.
14. Dalu A., Haskell J. F., Coward L., Lamartiniere C. A. Genistein, a component of soy, inhibits the expression of the EGF and ErbB2/Neu receptors in the rat dorsolateral prostate. Prostate. 37:1998;36-43.
15. Dobrinska M. R. Enterohepatic circulation of drugs. J. Clin. Pharmacol. 29:1989;577-580.
16. Enmark E., Huikko-Pelto M., Grandien K., Lagercrantz S., Lagercrantz J., Fried G., Nordenskjold M., Gustafsson J. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab. 82:1997;4258-4265.
17. Fritz W. A., Coward L., Wang J., Lamartiniere C. A. Dietary genistein: Perinatal mammary cancer prevention, bioavailibility and toxicity testing in the rat. Carcinogenesis. 19:1998;2151-2158.
18. Heinzel G., Woloszczak R., Thomann P. TopFit. Version 2.0. Pharmacokinetic and Pharmacodynamic Data Analysis System for the PC. 1993;Gustav Fischer Verlag, Stuttgart.
19. Jensen E. V., Jacobson H. I. Fate of steroid estrogens in target tissues. Pincus G., Vollmer E. P. Biological Activities of Steroids in Relation to Cancer. 1960;161-178 Academic Press, New York.
20. Joannou G. E., Kelly G. E., Reeder A. Y., Waring M., Nelson C. A. Urinary profile study of dietary phytoestrogens: The identification and mode of metabolism of new isoflavonoids. J. Steroid Biochem. Mol. Biol. 54:1995;167-184.
21. Kao Y-C., Zhou C., Sherman M., Laughton C. A., Chen S. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site directed mutagenicity study. Environ. Health Perspect. 106:1998;85-92.
22. Kelly G. E., Joannou G. E., Reeder A. Y., Nelson C., Waring M. A. The variable metabolic response to dietary isoflavones in humans. P.S.E.B.M. 208:1995;40-43.
23. King R. A., Broadbent J. L., Head R. J. Absorption and excretion of the soy isoflavone genistein in rats. J. Nutr. 126:1996;176-182.
24. Kuiper G. G. J. M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β Endocrinology. 138:1997;863-870.
25. Lin J. H., Chiba M., Baillie T. A. Is the role of the small intestine in first-pass metabolism overemphasised. Pharmacol. Rev. 51:1999;135-155.
26. Makela S., Poutanen M., Lehtimaki J., Kostian M.-L., Santti R., Vihko R. Estrogen-specific 17β-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogen. Proc. Soc. Exp. Biol. Med. 208:1995;51-59.
27. Markaverich B. M., Gregory R. R., Alejandro M. A., Clark J. H., Johnson G. A., Middleditch B. S. Methyl p-hydroxyphenyllacetate an inhibitor of cell growth and proliferation and an endogenous ligand for nuclear type II binding sites. J. Biol. Chem. 263:1988;7203-7210.
28. Messina M. J., Persky V., Setchell K. D. R., Barnes S. Soy intake and cancer risk: A review of the in vitro and in vivo data. Nutr. Cancer. 21:1994;113-131.
29. Miksicek R. J. Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J. Steroid Biochem. Mol. Biol. 49:1994;153-160.
30. Naim M., Gestetner B., Bondi A., Birk Y. Antioxidant and antihemolytic activity of soybean isoflavones. J. Agric. Food Chem. 24:1976;1174-1177.
31. Pang K. S. Kinetics of conjugation reactions in eliminating organs. Mulder G. J. Conjugation Reactions in Drug Metabolism. 1990;6-36 Taylor and Francis, London.
32. Santell R. C., Chang Y. C., Nair M., Helferich W. G. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J. Nutr. 127:1997;263-269.
33. Saunders P. T. K. Oestrogen receptor beta (ERβ). Rev. Reprod. 3:1998;164-171.
34. Setchell K. D. R. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 68s:1998;1333s-1346s.
35. Setchell K. D. R., Zimmer-Nechemias L., Cai J., Heubi J. E. Isoflavone content of infant formulas and their metabolic fate of phytoestrogens in early life. Am. J. Clin. Nutr. 68s:1998;1453s-1461s.
36. Sfakianos J., Coward L., Kirk M., Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J. Nutr. 127:1997;1260-1268.
37. Supko J. G., Malspeis L. Plasma pharmacokinetics of genistein in mice. Int. J. Oncol. 7:1995;847-854.
38. Ullberg S., Bengstsson G. Autoradiographic distribution studies with natural oestrogens. Acta Endocrinol. 43:1963;75-86.
39. Xu X., Wang H-J., Murphy P. A., Cook L., Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr. 124:1994;825-832.
40. Yasuda T., Mizunuma S., Kano Y., Saito K-I., Ohsawa K. Urinary and biliary metabolites of genistein in rats. Biol. Pharmacol. Bull. 19:1996;413-417.